Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Altoona › NPI 1649278730
Hospital

UPMC Altoona

UPMC Altoona was paid $19.67M by Medicaid between Jan 2018 and Dec 2024, across 465 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.

33Billing provider infoUPMC ALTOONA
ALTOONA, PA 16601
33aNPI1649278730assigned 07/12/2005
28Total paid$19.67M
24GClaims721,379
24DCodes billed465
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#15 of 154
Median peer was paid$2.82M
This provider vs. median7.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,195$27K
20191,522$31K
202072,368$1.69M
2021326,054$8.67M
2022102,736$2.86M
2023126,641$3.61M
2024incomplete90,863$2.78M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 24% 31,752 30,467 $4.68M
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 11% 61,401 55,717 $2.07M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.9% 16,366 15,831 $1.55M
G0378 Hospital observation service, per hour 7.7% 5,449 2,301 $1.52M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.0% 7,812 7,441 $1.38M
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 2.2% 4,836 2,638 $426K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.6% 3,605 2,051 $323K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.6% 2,453 2,369 $317K
80053 Comprehensive metabolic panel 1.5% 33,972 30,671 $301K
59400 Routine obstetric care including antepartum care, vaginal delivery, and postpartum care 1.5% 139 137 $297K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.3% 12,450 11,874 $247K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 51,588 43,942 $240K
453 more codes
80050 General health panel 1.0% 4,469 $201K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 1,172 $194K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 2,858 $185K
70450 Computed tomography, head or brain; without contrast material <1% 3,290 $171K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,298 $136K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 5,327 $128K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 5,271 $119K
84443 Thyroid stimulating hormone (TSH) <1% 5,430 $115K
99214 Doctor's office visit, returning patient (more involved) <1% 1,842 $110K
71275 Computed tomographic angiography, chest, with contrast material <1% 742 $108K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,507 $104K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 475 $96K
80061 Lipid panel <1% 7,428 $94K
T1001 Nursing assessment / evaluation <1% 503 $94K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 3,749 $93K
93458 <1% 121 $91K
96375 Therapeutic injection; each additional sequential IV push <1% 7,213 $90K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 198 $89K
78815 Positron emission tomography (PET) for limited area imaging <1% 105 $87K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 11,382 $84K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 484 $82K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 2,600 $80K
77067 Screening mammography, bilateral, including computer-aided detection <1% 983 $79K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,261 $78K
71046 Radiologic examination, chest; 2 views <1% 6,217 $76K
80048 Basic metabolic panel (calcium, ionized) <1% 11,169 $74K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 490 $69K
84484 <1% 8,452 $68K
87086 Culture, bacterial; quantitative colony count, urine <1% 9,540 $67K
77386 <1% 229 $57K
84703 <1% 6,797 $53K
70551 Magnetic resonance imaging, brain; without contrast material <1% 298 $53K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 203 $51K
72141 <1% 245 $50K
95811 <1% 132 $48K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 257 $48K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,055 $47K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,169 $46K
71250 <1% 880 $46K
80081 <1% 514 $45K
83880 <1% 1,817 $44K
83036 Hemoglobin; glycosylated (A1C) <1% 7,042 $41K
81001 <1% 16,577 $39K
J3490 Unclassified drugs <1% 14,768 $37K
84702 <1% 2,437 $36K
83735 <1% 7,043 $36K
Q3014 Telehealth originating site facility fee <1% 2,187 $35K
93971 <1% 604 $34K
70496 <1% 243 $34K
82607 <1% 3,523 $33K
96367 <1% 1,994 $33K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 525 $32K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 594 $32K
71045 Radiologic examination, chest; single view <1% 5,848 $32K
72125 Computed tomography, cervical spine; without contrast material <1% 630 $31K
70498 <1% 237 $31K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,029 $30K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 555 $28K
96417 <1% 708 $28K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 302 $28K
76830 Ultrasound, transvaginal <1% 711 $28K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 137 $27K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,050 $27K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 467 $27K
J2785 Injection, regadenoson, 0.1 mg <1% 707 $26K
87631 <1% 134 $26K
93970 <1% 369 $25K
77066 Tomosynthesis, mammo <1% 304 $24K
87040 <1% 2,127 $24K
73610 <1% 1,487 $23K
73221 <1% 107 $23K
86803 <1% 1,200 $23K
83540 <1% 3,145 $23K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 826 $23K
76536 <1% 502 $23K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 13 $22K
96361 Intravenous infusion, hydration; each additional hour <1% 1,318 $22K
80076 <1% 2,733 $22K
87480 <1% 938 $22K
87660 <1% 937 $22K
76801 <1% 611 $21K
82728 <1% 2,048 $21K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 696 $21K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 115 $21K
77063 Screening digital breast tomosynthesis, bilateral <1% 970 $21K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,903 $20K
87522 Neg quan hep c or qual rna <1% 484 $20K
83970 <1% 494 $20K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 417 $19K
87186 <1% 2,640 $19K
84439 <1% 2,513 $18K
99213 Doctor's office visit, returning patient (routine) <1% 436 $18K
87077 <1% 2,705 $18K
77065 Tomosynthesis, mammo <1% 306 $17K
88342 <1% 744 $17K
93880 <1% 304 $17K
86618 <1% 749 $17K
76642 <1% 457 $17K
96415 <1% 596 $17K
76770 <1% 445 $17K
85610 <1% 6,248 $16K
73630 <1% 1,609 $16K
78227 <1% 55 $15K
72131 <1% 282 $15K
83690 <1% 4,369 $15K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 10,089 $15K
72100 <1% 850 $15K
81002 <1% 3,704 $15K
80074 <1% 279 $15K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 337 $14K
82784 <1% 720 $13K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 306 $13K
70486 <1% 249 $13K
83615 <1% 2,131 $13K
73562 <1% 975 $12K
83550 <1% 2,800 $12K
84146 <1% 578 $12K
93923 <1% 265 $12K
72110 <1% 606 $12K
73030 <1% 959 $12K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 315 $12K
74183 <1% 33 $11K
95886 <1% 209 $11K
85379 <1% 1,504 $11K
87081 <1% 2,106 $11K
86038 <1% 747 $11K
88313 <1% 384 $11K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 841 $11K
73130 <1% 1,093 $11K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 290 $10K
85730 <1% 2,347 $10K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 27 $10K
87070 <1% 1,716 $10K
90715 <1% 1,282 $10K
84153 <1% 467 $10K
86706 <1% 739 $10K
73110 <1% 983 $10K
72128 <1% 168 $10K
94729 <1% 336 $10K
74178 <1% 55 $10K
84100 <1% 1,896 $10K
87481 <1% 344 $10K
73502 <1% 606 $10K
96411 <1% 178 $10K
82805 <1% 384 $9K
84403 <1% 343 $9K
82746 <1% 1,218 $9K
93922 <1% 449 $9K
72050 <1% 378 $9K
83605 <1% 1,602 $9K
93017 <1% 288 $9K
82043 <1% 1,110 $8K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,228 $8K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 538 $8K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 1,956 $8K
88341 <1% 314 $8K
74018 <1% 666 $8K
82105 <1% 396 $8K
47562 <1% 12 $7K
87340 <1% 523 $7K
85651 <1% 2,715 $7K
87205 <1% 1,837 $7K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 191 $7K
73564 <1% 389 $7K
93926 <1% 125 $7K
83013 <1% 243 $7K
93976 <1% 111 $7K
J0185 Injection, aprepitant, 1 mg <1% 306 $7K
J1815 Injection, insulin, per 5 units <1% 683 $6K
94060 <1% 586 $6K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 119 $6K
86140 <1% 2,347 $6K
70491 <1% 98 $6K
77336 <1% 172 $6K
10005 <1% 12 $6K
94727 <1% 303 $6K
86850 <1% 993 $6K
82378 <1% 430 $6K
76870 <1% 152 $6K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 68 $6K
93226 <1% 173 $6K
83001 <1% 327 $5K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 249 $5K
83655 <1% 480 $5K
G0008 Administration of influenza virus vaccine <1% 574 $5K
82570 <1% 793 $5K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 58 $5K
86800 <1% 269 $5K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 52 $5K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 505 $5K
87209 <1% 249 $5K
82950 <1% 724 $5K
73590 <1% 366 $5K
85027 <1% 1,182 $5K
82670 <1% 226 $5K
93320 <1% 139 $5K
80329 <1% 408 $5K
J1756 Injection, iron sucrose, 1 mg <1% 1,407 $5K
84550 <1% 823 $4K
72072 <1% 254 $4K
84402 <1% 157 $4K
86617 <1% 109 $4K
96523 <1% 369 $4K
86713 <1% 213 $4K
72040 <1% 302 $4K
73080 <1% 453 $4K
73521 <1% 249 $4K
82947 <1% 1,189 $4K
82962 <1% 3,206 $4K
84145 <1% 315 $4K
86235 <1% 89 $4K
J1170 Injection, hydromorphone, up to 4 mg <1% 7,623 $4K
82977 <1% 444 $4K
88360 <1% 221 $4K
82550 <1% 629 $4K
86592 <1% 852 $4K
36430 <1% 96 $3K
83002 <1% 213 $3K
86480 <1% 48 $3K
59025 Fetal non-stress test <1% 599 $3K
80197 <1% 209 $3K
81025 <1% 973 $3K
80069 <1% 386 $3K
80164 <1% 187 $3K
97161 <1% 308 $3K
86900 <1% 1,118 $3K
86430 <1% 461 $3K
86901 <1% 1,100 $3K
81329 <1% 27 $3K
84165 <1% 255 $3K
77049 <1% 15 $3K
86334 <1% 135 $3K
82330 <1% 471 $3K
99407 <1% 176 $3K
86003 <1% 77 $3K
87329 <1% 233 $3K
72170 <1% 384 $3K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,037 $3K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 141 $3K
86765 <1% 219 $3K
85018 <1% 893 $3K
82248 <1% 356 $3K
82533 <1% 220 $3K
86039 <1% 179 $3K
84450 <1% 391 $3K
86708 <1% 173 $3K
93225 <1% 173 $3K
84156 <1% 637 $2K
86762 <1% 135 $2K
84132 <1% 566 $2K
82677 <1% 133 $2K
73552 <1% 163 $2K
88142 <1% 145 $2K
83010 <1% 197 $2K
72082 <1% 70 $2K
82172 <1% 120 $2K
73090 <1% 228 $2K
S9470 Nutritional counseling, dietitian visit <1% 283 $2K
86376 <1% 273 $2K
96368 <1% 277 $2K
86704 <1% 139 $2K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 42 $2K
84481 <1% 96 $2K
90682 <1% 141 $2K
87045 <1% 312 $2K
86255 <1% 90 $2K
72146 <1% 14 $2K
88112 <1% 75 $2K
83721 <1% 204 $2K
87177 <1% 246 $2K
76937 <1% 394 $2K
84295 <1% 447 $2K
86665 <1% 50 $2K
82626 <1% 94 $2K
86200 <1% 130 $2K
85014 <1% 575 $2K
77334 <1% 38 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,778 $2K
C9399 Unclassified drugs or biologicals <1% 280 $2K
73140 <1% 224 $2K
97162 <1% 282 $2K
84436 <1% 165 $2K
J0690 Injection, cefazolin sodium, 500 mg <1% 4,328 $2K
80177 <1% 129 $1K
82565 <1% 377 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,205 $1K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 208 $1K
87210 <1% 246 $1K
41899 Unlisted procedure, dentoalveolar structures <1% 71 $1K
84520 <1% 292 $1K
82375 <1% 385 $1K
93325 <1% 55 $1K
87046 <1% 318 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 924 $1K
82140 <1% 337 $1K
71101 <1% 116 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 9,847 $1K
J3370 Injection, vancomycin hcl, 500 mg <1% 1,227 $1K
86780 <1% 87 $1K
73560 <1% 97 $1K
87400 <1% 78 $1K
95912 <1% 16 $1K
84480 <1% 157 $1K
81000 <1% 250 $1K
84134 <1% 67 $1K
88738 <1% 282 $1K
80175 <1% 73 $1K
86300 <1% 51 $1K
82150 <1% 250 $1K
86160 <1% 37 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,090 $1K
97166 <1% 186 $1K
84144 <1% 67 $1K
J1644 Injection, heparin sodium, per 1000 units <1% 2,927 $997.45
82747 <1% 40 $979.33
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 16,195 $963.40
87625 <1% 34 $960.24
95816 <1% 105 $950.15
76775 <1% 25 $946.97
83993 <1% 42 $934.71
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 184 $922.26
86664 <1% 44 $889.74
J2805 Injection, sincalide, 5 micrograms <1% 12 $869.76
86317 <1% 30 $857.07
95819 <1% 98 $841.88
36415 Collection of venous blood by venipuncture <1% 3,949 $803.12
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,002 $782.98
83525 <1% 73 $759.54
86304 <1% 38 $756.14
93312 <1% 15 $755.38
84681 <1% 26 $730.54
82310 <1% 117 $726.68
83050 <1% 386 $725.84
J1626 Injection, granisetron hydrochloride, 100 mcg <1% 1,702 $672.79
J3010 Injection, fentanyl citrate, 0.1 mg <1% 7,144 $669.91
96156 <1% 12 $669.45
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 1,038 $667.90
36600 <1% 90 $655.60
86787 <1% 32 $557.80
86703 <1% 30 $552.53
20610 <1% 15 $548.62
J0640 Injection, leucovorin calcium, per 50 mg <1% 135 $541.41
84425 <1% 83 $524.67
J0780 Injection, prochlorperazine, up to 10 mg <1% 933 $522.06
97165 <1% 134 $510.01
29581 <1% 38 $478.37
82040 <1% 182 $458.54
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 1,412 $449.99
86705 <1% 28 $436.85
82985 <1% 25 $434.94
85045 <1% 119 $421.73
86147 <1% 16 $415.13
80178 <1% 64 $413.27
86580 <1% 67 $410.14
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,805 $398.93
82785 <1% 24 $398.22
74246 <1% 12 $397.20
73060 <1% 53 $392.12
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,819 $390.69
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,375 $384.38
J3475 Injection, magnesium sulfate, per 500 mg <1% 965 $375.06
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 168 $372.47
86769 <1% 29 $354.35
72070 <1% 27 $344.26
99153 Mod sedat endo service >5yrs <1% 46 $343.98
84432 <1% 15 $337.98
96402 <1% 16 $336.10
S0028 Injection, famotidine, 20 mg <1% 2,126 $332.32
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 525 $322.55
J9045 Injection, carboplatin, 50 mg <1% 84 $320.83
82010 <1% 79 $291.72
J7050 Infusion, normal saline solution, 250 cc <1% 4,243 $288.58
92611 <1% 16 $285.26
83498 <1% 12 $273.89
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 854 $271.68
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,736 $264.54
99152 <1% 193 $246.54
70360 <1% 26 $243.90
88307 <1% 147 $240.12
88304 <1% 325 $237.17
85613 <1% 15 $235.34
94644 <1% 12 $223.59
96376 <1% 395 $222.39
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 7,315 $220.44
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 168 $219.13
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 112 $217.15
73000 <1% 24 $216.71
76942 <1% 26 $199.02
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 6,282 $176.81
J2060 Injection, lorazepam, 2 mg <1% 1,650 $169.76
80055 <1% 13 $163.20
82951 <1% 13 $158.03
85347 <1% 14 $153.95
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 182 $153.82
82272 <1% 44 $152.46
J3489 Injection, zoledronic acid, 1 mg <1% 24 $151.83
C1769 Guide wire <1% 164 $143.70
J1030 Injection, methylprednisolone acetate, 40 mg <1% 113 $139.99
J2704 Injection, propofol, 10 mg <1% 3,563 $138.64
84479 <1% 13 $131.56
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 115 $110.69
87220 <1% 24 $104.40
J7999 Compounded drug, not otherwise classified <1% 2,648 $104.03
J7120 Ringers lactate infusion, up to 1000 cc <1% 982 $92.71
J1953 Injection, levetiracetam, 10 mg <1% 33 $80.00
87075 <1% 15 $70.60
89050 <1% 29 $64.64
86308 <1% 13 $61.52
87430 <1% 12 $55.76
84075 <1% 12 $52.17
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 26 $46.67
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 240 $45.62
94761 <1% 336 $43.20
J0360 Injection, hydralazine hcl, up to 20 mg <1% 62 $41.13
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 1,907 $38.02
83986 <1% 26 $37.76
81003 <1% 12 $37.16
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 2,477 $33.55
J3480 Injection, potassium chloride, per 2 meq <1% 237 $23.20
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 128 $23.20
85049 <1% 29 $23.10
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 169 $14.90
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 16 $13.92
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 904 $12.26
S0077 Injection, clindamycin phosphate, 300 mg <1% 53 $10.58
J1940 Injection, furosemide, up to 20 mg <1% 19 $7.65
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 734 $3.00
Q0243 Injection, casirivimab and imdevimab, 2400 mg <1% 29 $0.09
90674 0% 329 $0.00
J0461 Injection, atropine sulfate, 0.01 mg 0% 59 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 433 $0.00
84311 0% 12 $0.00
90673 0% 65 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 0% 304 $0.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 0% 110 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 53 $0.00
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) 0% 69 $0.00
90677 0% 53 $0.00
J8501 Aprepitant, oral, 5 mg 0% 13 $0.00
J9267 Injection, paclitaxel, 1 mg 0% 84 $0.00
36591 0% 21 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 22 $0.00
90661 0% 79 $0.00
J0692 Injection, cefepime hydrochloride, 500 mg 0% 123 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 232 $0.00
J9271 Injection, pembrolizumab, 1 mg 0% 204 $0.00
J0736 Injection, clindamycin phosphate, 300 mg 0% 69 $0.00
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg 0% 12 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 258 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 45 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 14 $0.00
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 0% 28 $0.00
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 0% 23 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKLATT, MONICA (CFO)
Parent organizationUPMC ALTOONA
Same official

Other billing entities under KLATT, MONICA

Full network →
ProviderLocationPaid
UPMC Bedford MemorialEverett, PA$3.80M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.